MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population

Ann Hepatol. 2024 Feb 23:101488. doi: 10.1016/j.aohep.2024.101488. Online ahead of print.NO ABSTRACTPMID:38403071 | DOI:10.1016/j.aohep.2024.101488

Source: Annals of Hepatology - February 25, 2024 Category: Gastroenterology Authors: You Deng Wenya Chen Wen Xie Source Type: research